Details

Autor(en) / Beteiligte

• Vasudevaraja, Varshini
• Rodriguez, Javier Hernaez
• Pelorosso, Cristiana
• Zhu, Kaicen
• Buccoliero, Anna Maria
• Onozato, Maristela
• Mohamed, Hussein
• Serrano, Jonathan
• Tredwin, Lily
• Garonzi, Marianna
• Forcato, Claudio
• Zeck, Briana
• Ramaswami, Sitharam
• Stafford, James
• Faustin, Arline
• Friedman, Daniel
• Hidalgo, Eveline Teresa
• Zagzag, David
• Skok, Jane
• Heguy, Adriana
• Chiriboga, Luis
• Conti, Valerio
• Guerrini, Renzo
• Iafrate, A John
• Devinsky, Orrin
• Tsirigos, Aristotelis
• Golfinos, John G
• Snuderl, Matija

Titel

Somatic Focal Copy Number Gains of Noncoding Regions of Receptor Tyrosine Kinase Genes in Treatment-Resistant Epilepsy

Ist Teil von

• Journal of neuropathology and experimental neurology, 2021-02, Vol.80 (2), p.160-168

Ort / Verlag

England: Oxford University Press

Erscheinungsjahr

2021

Link zum Volltext

Quelle

Oxford Journals 2020 Medicine

Beschreibungen/Notizen

• Abstract Epilepsy is a heterogenous group of disorders defined by recurrent seizure activity due to abnormal synchronized activity of neurons. A growing number of epilepsy cases are believed to be caused by genetic factors and copy number variants (CNV) contribute to up to 5% of epilepsy cases. However, CNVs in epilepsy are usually large deletions or duplications involving multiple neurodevelopmental genes. In patients who underwent seizure focus resection for treatment-resistant epilepsy, whole genome DNA methylation profiling identified 3 main clusters of which one showed strong association with receptor tyrosine kinase (RTK) genes. We identified focal copy number gains involving epidermal growth factor receptor (EGFR) and PDGFRA loci. The dysplastic neurons of cases with amplifications showed marked overexpression of EGFR and PDGFRA, while glial and endothelial cells were negative. Targeted sequencing of regulatory regions and DNA methylation analysis revealed that only enhancer regions of EGFR and gene promoter of PDGFRA were amplified, while coding regions did not show copy number abnormalities or somatic mutations. Somatic focal copy number gains of noncoding regulatory represent a previously unrecognized genetic driver in epilepsy and a mechanism of abnormal activation of RTK genes. Upregulated RTKs provide a potential avenue for therapy in seizure disorders.